These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Comparison of the safety and tolerance of intravenous anisoylated plasminogen streptokinase activator complex and intracoronary streptokinase in acute myocardial infarction. de Swart JB Drugs; 1987; 33 Suppl 3():279-81. PubMed ID: 3315607 [No Abstract] [Full Text] [Related]
7. Coronary thrombolytic therapy: state of the art. Marx M; Levin DC AJR Am J Roentgenol; 1986 Jul; 147(1):1-8. PubMed ID: 3521234 [TBL] [Abstract][Full Text] [Related]
12. Dose-ranging studies of anisoylated plasminogen streptokinase activator complex. Studies in healthy volunteers and in patients with acute myocardial infarction. Marder VJ; Rothbard RL; Fitzpatrick PG; Francis CW; Norry EC Drugs; 1987; 33 Suppl 3():124-32. PubMed ID: 3315577 [TBL] [Abstract][Full Text] [Related]
13. Thrombolysis during acute myocardial infarction. Lew AS; Ganz W Acute Care; 1985; 11(1):3-39. PubMed ID: 2940795 [No Abstract] [Full Text] [Related]
14. Effect of intracoronary streptokinase administered immediately after primary percutaneous coronary intervention on long-term left ventricular infarct size, volumes, and function. Sezer M; Cimen A; Aslanger E; Elitok A; Umman B; Buğra Z; Yormaz E; Türkmen C; Adalet IS; Nişanci Y; Umman S J Am Coll Cardiol; 2009 Sep; 54(12):1065-71. PubMed ID: 19744615 [TBL] [Abstract][Full Text] [Related]
15. The role of intracoronary thrombolysis and percutaneous transluminal coronary angioplasty in evolving myocardial infarction. DiSciascio G; Cowley MJ Cardiol Clin; 1985 Feb; 3(1):73-83. PubMed ID: 2935256 [TBL] [Abstract][Full Text] [Related]
16. Rapid infusion of streptokinase standard dose in acute myocardial infarction is followed by a higher rate of coronary reperfusion than standard protocol. Tatu-Chiţoiu G; Orha I; Teodorescu C; Flueraşu A; Serban L; Bumbu A Rom J Intern Med; 1997; 35(1-4):47-54. PubMed ID: 9562652 [TBL] [Abstract][Full Text] [Related]
17. Tolerance and complications in a multicenter trial of intravenous APSAC and intracoronary streptokinase in acute myocardial infarction. Rothbard RL; Anderson JL; Fitzpatrick PG; Hakworthy RA; Sorensen SG; Marder VJ Clin Cardiol; 1990 Mar; Suppl 5():V11-4; discussion V27-32. PubMed ID: 2182234 [TBL] [Abstract][Full Text] [Related]
18. Percutaneous transluminal coronary angioplasty, alone or in combination with streptokinase therapy, during acute myocardial infarction. Holmes DR; Smith HC; Vlietstra RE; Nishimura RA; Reeder GS; Bove AA; Bresnahan JF; Chesebro JH; Piehler JM Mayo Clin Proc; 1985 Jul; 60(7):449-56. PubMed ID: 3159944 [TBL] [Abstract][Full Text] [Related]
19. Is coronary thrombolysis associated with side effects that significantly compromise clinical benefits? Gurewich V; Muller J Am J Cardiol; 1996 Apr; 77(9):756-8. PubMed ID: 8651129 [No Abstract] [Full Text] [Related]